Trials / Completed
CompletedNCT00812006
A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Crossover Trial to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg ODT for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 108 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will provide additional efficacy data for rizatriptan when used for an acute migraine attack in patients already taking topiramate for migraine prophylaxis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rizatriptan benzoate | rizatriptan 10 mg Orally Disintegrating Tablet (ODT) orally for a moderate or severe migraine attack |
| DRUG | Comparator: placebo | Placebo to rizatriptan 10 mg ODT orally for a moderate or severe migraine attack |
Timeline
- Start date
- 2009-03-24
- Primary completion
- 2009-10-22
- Completion
- 2009-10-22
- First posted
- 2008-12-19
- Last updated
- 2024-05-23
- Results posted
- 2011-01-27
Source: ClinicalTrials.gov record NCT00812006. Inclusion in this directory is not an endorsement.